DOI QR코드

DOI QR Code

Identification of P-Glycoprotein and Transport Mechanism of Paclitaxel in Syncytiotrophoblast Cells

  • Lee, Na-Young (College of Pharmacy and Research Center for Cell Fate Control, Sookmyung Women's University) ;
  • Lee, Ha-Eun (College of Pharmacy and Research Center for Cell Fate Control, Sookmyung Women's University) ;
  • Kang, Young-Sook (College of Pharmacy and Research Center for Cell Fate Control, Sookmyung Women's University)
  • Received : 2013.12.16
  • Accepted : 2014.01.16
  • Published : 2014.01.31

Abstract

When chemotherapy is administered during pregnancy, it is important to consider the fetus chemotherapy exposure, because it may lead to fetal consequences. Paclitaxel has become widely used in the metastatic and adjuvant settings for woman with cancer including breast and ovarian cancer. Therefore, we attempted to clarify the transport mechanisms of paclitaxel through blood-placenta barrier using rat conditionally immortalized syncytiotrophoblast cell lines (TR-TBTs). The uptake of paclitaxel was time- and temperature-dependent. Paclitaxel was eliminated about 50% from the cells within 30 min. The uptake of paclitaxel was saturable with $K_m$ of $168{\mu}M$ and $371{\mu}M$ in TR-TBT 18d-1 and TR-TBT 18d-2, respectively. [$^3H$]Paclitaxel uptake was markedly inhibited by cyclosporine and verapamil, well-known substrates of P-glycoprotein (P-gp) transporter. However, several MRP substrates and organic anions had no effect on [$^3H$]paclitaxel uptake in TR-TBT cells. These results suggest that P-gp may be involved in paclitaxel transport at the placenta. TR-TBT cells expressed mRNA of P-gp. These findings are important for therapy of breast and ovarian cancer of pregnant women, and should be useful data in elucidating teratogenicity of paclitaxel during pregnancy.

Keywords

References

  1. Chishu, T., Sai, Y., Nishimura, T., Sato, K., Kose, N., Nakashima, E. (2008) Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1. Placenta 29, 461-467. https://doi.org/10.1016/j.placenta.2008.01.010
  2. De Santis, M., Lucchese, A., De Carolis, S., Ferrazani, S., Caruso, A. (2000) Metastatic breast cancer in pregnancy: first case of chemotherapy with docetaxel. Eur. J. Cancer Care 9, 235-237. https://doi.org/10.1046/j.1365-2354.2000.00231.x
  3. Fromm, M. F. (2004) Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol. Sci. 25, 423-429. https://doi.org/10.1016/j.tips.2004.06.002
  4. Gonzalez-Angulo, A. M., Walters, R. S., Carpenter, R. J. Jr, Ross, M. I., Perkins, G. H., Gwyn, K., Theriault, R. L. (2004) Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin. Breast Cancer 5, 317-319. https://doi.org/10.3816/CBC.2004.n.037
  5. Kitano, T., Iizasa, H., Hwang, I. W., Hirose, Y., Morita, T., Maeda, T., Nakashima, E. (2004) Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood-placenta barrier. Biol. Pharm. Bull. 27, 753-759. https://doi.org/10.1248/bpb.27.753
  6. Kitano, T., Iizasa, H., Terasaki, T., Asashima, T., Matsunaga, N., Utoguchi, N., Watanabe, Y., Obinata, M., Ueda, M., Nakashima, E. (2002) Polarized glucose transporters and mRNA expression properties in newly developed rat syncytiotrophoblast cell lines, TR-TBTs. J. Cell. Physiol. 193, 208-218. https://doi.org/10.1002/jcp.10165
  7. Lee, N. Y., Choi, H. M., Kang, Y. S. (2009) Choline transport via choline transporter-like protein 1 in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBT. Placenta 30, 368-374. https://doi.org/10.1016/j.placenta.2009.01.011
  8. Lee, N. Y., Sai, Y., Nakashima, E., Ohtsuki, S., Kang, Y. S. (2011) 6-Mercaptopurine transport by equilibrative nucleoside transporters in conditionally immortalized rat syncytiotrophoblast cell lines TR-TBTs. J. Pharm. Sci. 100, 3773-3782. https://doi.org/10.1002/jps.22631
  9. Mao, Q. (2008) BCRP/ABCG2 in the placenta: expression, function and regulation. Pharm. Res. 25, 1244-1255. https://doi.org/10.1007/s11095-008-9537-z
  10. Mendez, L. E., Mueller, A., Salom, E., Gonzalez-Quintero, V. H. (2003) Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer. Obstet. Gynecol. 102, 1200-1202. https://doi.org/10.1016/S0029-7844(03)00698-7
  11. Mir, O., Berveiller, P., Goffinet, F., Treluyer, J. M., Serreau, R., Goldwasser, F., Rouzier, R. (2010) Taxanes for breast cancer during pregnancy: a systematic review. Ann. Oncol. 21, 425-426. https://doi.org/10.1093/annonc/mdp517
  12. Murray, S., Briasoulis, E., Linardou, H., Bafaloukos, D., Papadimitriou, C. (2012) Taxane resistance in breast cancer: mechanisms, predictive biomarkers and circumvention strategies. Cancer Treat. Rev. 38, 890-903. https://doi.org/10.1016/j.ctrv.2012.02.011
  13. Sai, Y., Nishimura, T., Shimpo, S., Chishu, T., Sato, K., Kose, N., Terasaki, T., Mukai, C., Kitagaki, S., Miyakoshi, N., Kang, Y. S., Nakashima, E. (2008) Characterization of the mechanism of zidovudine uptake by rat conditionally immortalized syncytiotrophoblast cell line TR-TBT. Pharm. Res. 25, 1647-1653. https://doi.org/10.1007/s11095-008-9564-9
  14. Sato, K., Sai, Y., Nishimura, T., Chishu, T., Shimpo, S., Kose, N., Nakashima, E. (2009) Influx mechanism of 2',3'-dideoxyinosine and uridine at the blood-placenta barrier. Placenta 30, 263-269. https://doi.org/10.1016/j.placenta.2008.11.022
  15. Smit, J. W., Huisman, M. T., van Tellingen, O., Wiltshire, H. R., Schinkel, A. H. (1999) Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J. Clin. Invest. 104, 1441-1447. https://doi.org/10.1172/JCI7963
  16. Sood, A. K., Shahin, M. S., Sorosky, J. I. (2001) Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol. Oncol. 83, 599-600. https://doi.org/10.1006/gyno.2001.6439
  17. Staud, F., Cerveny, L., Ceckova, M. (2012) Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. J. Drug Target. 20, 736-763. https://doi.org/10.3109/1061186X.2012.716847
  18. Takata, K., Hirano, H. (1997) Mechanism of glucose transport across the human and rat placental barrier: a review. Microsc. Res. Tech. 38, 145-152. https://doi.org/10.1002/(SICI)1097-0029(19970701/15)38:1/2<145::AID-JEMT15>3.0.CO;2-P
  19. Van Calsteren, K., Heyns, L., De Smet, F., Van Eycken, L., Gziri, M. M., Van Gemert, W., Halaska, M., Vergote, I., Ottevanger, N., Amant, F. (2010) Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J. Clin. Oncol. 28, 683-689. https://doi.org/10.1200/JCO.2009.23.2801
  20. Van Calsteren, K., Verbesselt, R., Van Bree, R., Heyns, L., de Bruijn, E., de Hoon, J., Amant, F. (2011) Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod. Sci. 18, 57-63. https://doi.org/10.1177/1933719110379650

Cited by

  1. Interactions Between Inflammatory Bowel Disease Drugs and Chemotherapy vol.14, pp.4, 2016, https://doi.org/10.1007/s11938-016-0109-8
  2. Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study vol.6, pp.1, 2015, https://doi.org/10.1186/s13287-015-0140-z
  3. Benzo[b]tryptanthrin Inhibits MDR1, Topoisomerase Activity, and Reverses Adriamycin Resistance in Breast Cancer Cells vol.10, pp.5, 2015, https://doi.org/10.1002/cmdc.201500068
  4. Placental ABC Transporters: Biological Impact and Pharmaceutical Significance vol.33, pp.12, 2016, https://doi.org/10.1007/s11095-016-2028-8
  5. Human Olfactory Bulb Neural Stem Cells (Hu-OBNSCs) Can Be Loaded with Paclitaxel and Used to Inhibit Glioblastoma Cell Growth vol.11, pp.1, 2019, https://doi.org/10.3390/pharmaceutics11010045
  6. Placental P-glycoprotein inhibition enhances susceptibility to Di-(2-ethylhexyl)-phthalate induced cardiac malformations in mice: A possibly promising target for congenital heart defects prevention vol.14, pp.5, 2014, https://doi.org/10.1371/journal.pone.0214873
  7. Involvement of a Novel Organic Cation Transporter in Paeonol Transport Across the Blood-Brain Barrier vol.27, pp.3, 2014, https://doi.org/10.4062/biomolther.2019.007
  8. Cancer during Pregnancy: A Review of Preclinical and Clinical Transplacental Transfer of Anticancer Agents vol.13, pp.6, 2021, https://doi.org/10.3390/cancers13061238
  9. Formulation effects on paclitaxel transfer and uptake in the human placenta vol.33, pp.None, 2014, https://doi.org/10.1016/j.nano.2020.102354
  10. Balancing the efficacy vs. the toxicity of promiscuous natural products: Paclitaxel-based acid-labile lipophilic prodrugs as promising chemotherapeutics vol.227, pp.None, 2022, https://doi.org/10.1016/j.ejmech.2021.113891